Granules India Limited — Updates, 19-12-2025: General Updates
19-12-2025 | 07:43 pm
19-12-2025 | 07:43 pm
Granules' subsidiary, Granules Life Sciences, completed an FDA inspection with 5 procedural observations. Importantly, no issues related to data integrity or product safety were found. The company commits to a prompt response.
No comments yet. Be the first to comment!
